Oncodesign Precision Medicine: Report of the annual General Meeting of 30 May 2023
Nomination of Florence Dupré as a member of the Board of Directors Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing
Source: finanznachrichten.de